GenBio AI Information

GenBio AI is an AI for Science company on a mission to make biology fully computable. The company is building an AI-Driven Digital Organism (AIDO) to simulate living systems, decode biology holistically, and accelerate medical and scientific research, thereby transforming medicine and healthcare to benefit humanity. AIDO Cell — a world model that simulates a cell's biology from molecules to whole-cell behavior — is the first step toward that larger mission. Our goal is to achieve actionable capabilities in simulating human physiology and disease. Based on such understanding we will use AIDO to design interventions, treatments and therapeutics which will pave the way for a new paradigm in drug design, bio-engineering, personalized medicine, and fundamental biomedical research. Our founding team consists of world-renowned scientists and researchers in AI and Biology from prestigious institutions including Stanford, CMU, MBZUAI, Weizmann, UW and Harvard, alongside prominent financial investors. Founded in 2024, GenBio AI is a global venture headquartered in Palo Alto, California, with labs in Paris and Abu Dhabi.